|
Anticipatory Nausea
& Vomiting (ANV)
It is well documented
that patients being treated with cytotoxic drugs may begin to
develop nausea and vomiting in expectation of their chemotherapy
treatment.
Question
4.1
What percent of patients
do you think develop anticipatory nausea and vomiting (ANV) by
the fourth treatment cycle?
 | Less
than 10% of patients |
 | Approximately
30% of patients |
 | Approximately
60% of patients |
 | More
than 90% of patients |
|